Mark A. Kronenfeld
Director · Pacira BioSciences, Inc.
Individual
- 2026
- Mar 19, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark A. Kronenfeld files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shawn Cross - $895K in PCRX purchases and sales in the last 12 months
- Kristen Williams - $498K in PCRX purchases and sales in the last 12 months
- Lauren Riker - $445K in PCRX purchases and sales in the last 12 months
- Jonathan Slonin - $240K in PCRX purchases and sales in the last 12 months
- Mark Froimson - $11K in PCRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark A. Kronenfeld?
Mark A. Kronenfeld is a corporate insider, tracked as Director of Pacira BioSciences, Inc. (PCRX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mark A. Kronenfeld last file a Form 4?
The only primary Form 4 on record is dated 19 March 2026.
